Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
166.245 USD
0.96%
Updated:
Apr 19, 2024
Abbvie Inc
Cash Taxes Paid
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Cash Taxes Paid Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Cash Taxes Paid Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash Taxes Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash Taxes Paid
$4.7B
|
CAGR 3-Years
41%
|
CAGR 5-Years
166%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash Taxes Paid
$4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
14%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash Taxes Paid
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
12%
|
CAGR 10-Years
27%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash Taxes Paid
$1.7B
|
CAGR 3-Years
106%
|
CAGR 5-Years
167%
|
CAGR 10-Years
82%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash Taxes Paid
$870.3m
|
CAGR 3-Years
67%
|
CAGR 5-Years
33%
|
CAGR 10-Years
95%
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Cash Taxes Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Cash Taxes Paid?
Cash Taxes Paid
4.7B
USD
4.7B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Cash Taxes Paid amounts to 4.7B USD.
What is Abbvie Inc's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 5Y
166%
166%
Over the last year, the Cash Taxes Paid growth was 57%. The average annual Cash Taxes Paid growth rates for Abbvie Inc have been 41% over the past three years , 166% over the past five years .
You don't have any saved screeners yet
